Wells Fargo & Company Ishares Tr Genomics Immunology Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Wells Fargo & Company holds 1,951 shares of IDNA stock, worth $45,107. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,951
Previous 3,859
49.44%
Holding current value
$45,107
Previous $88,000
47.73%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IDNA
# of Institutions
66Shares Held
1.84MCall Options Held
0Put Options Held
0-
Ubs Group Ag324KShares$7.49 Million0.0% of portfolio
-
Wharton Business Group, LLC Malvern, PA270KShares$6.23 Million0.31% of portfolio
-
Bank Of America Corp Charlotte, NC266KShares$6.15 Million0.0% of portfolio
-
Morgan Stanley New York, NY112KShares$2.59 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY99.3KShares$2.29 Million0.0% of portfolio